Trilobio, developer of whole lab automation solutions for advancing biology research, today introduced the first version of its comprehensive robotics, lab equipment and software platform at the ...
Presentations in this conference track covered the latest technological advances and methods in microfluidics devices. In the keynote address “Commercialization and Entrepreneurial Lessons from ...
SPT Labtech and EMBL GeneCore collaborate to advance fully walkaway automation in genomics workflows
SPT Labtech, a global leader in the design and development of laboratory automation and liquid handling solutions, and the ...
Stay up to date on the latest science with Brush Up Summaries. This Brush Up is sponsored by Bio-Techne. Both semi-automated and fully automated workflows reduce ...
Opinion
12don MSNOpinion
AI can design and run thousands of lab experiments without human hands. Humanity isn’t ready for the new risks this brings to biology
Artificial intelligence is rapidly learning to autonomously design and run biological experiments, but the systems intended to govern those capabilities are struggling to keep pace. AI company OpenAI ...
High-throughput experimentation paired with mass spectrometry (MS) is accelerating drug discovery by enabling rapid, parallel analysis of thousands of chemical reactions and biological assays. While ...
When automation technology first became available for drug discovery, the equipment was expensive and fairly complex to use, and needed a lot of attention and maintenance to stay up-and-running. This ...
“Before COVID, if I said we need to reproduce or scale, people would ask, why?” says Doug Densmore, Co-Founder of Lattice Automation and Asimov. “Now, people get it.” The consequence? An automated ...
Forbes contributors publish independent expert analyses and insights. Gary Drenik is a writer covering AI, analytics and innovation. No topic has been discussed more than Covid-19 in the past two ...
Jabil and HSE have formed a strategic collaboration to streamline the design, development, and scalable production of ...
The world’s labs are under pressure to do more tests and process more materials, not just due to COVID but from the growing biotech and drug development sectors — and automation is the sure path ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results